Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response study of intrathecal 2% lidocaine for cesarean delivery
ChiCTR2000033421Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in None (4 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Success rate of anesthesia. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
lidocaine
Beyond the preview
Go deeper on ChiCTR2000033421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033421.